Pablo Sanchez to Transplant Recipients
This is a "connection" page, showing publications Pablo Sanchez has written about Transplant Recipients.
Connection Strength
1.561
-
National Trends in Extended Criteria Donor Utilization and Outcomes for Lung Transplantation. Ann Thorac Surg. 2021 02; 111(2):421-426.
Score: 0.651
-
Risk Factors and Outcomes Associated With the Development of Persistent Acute Kidney Injury in Non-Renal Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis. Clin Transplant. 2024 Sep; 38(9):e15444.
Score: 0.217
-
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients. Clin Infect Dis. 2021 08 02; 73(3):416-426.
Score: 0.175
-
The Impact of Donor Asphyxiation or Drowning on Pediatric Lung Transplant Recipients. Transplantation. 2021 03 01; 105(3):620-627.
Score: 0.170
-
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. J Heart Lung Transplant. 2020 12; 39(12):1417-1425.
Score: 0.165
-
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications. Am J Transplant. 2023 10; 23(10):1590-1602.
Score: 0.050
-
Incidence of Acute Cellular Rejection After Granulocyte Colony-Stimulating Factor in Lung Transplant Recipients. J Pharm Pract. 2024 Aug; 37(4):830-837.
Score: 0.050
-
Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans. Am J Transplant. 2022 02; 22(2):574-587.
Score: 0.044
-
Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. Am J Transplant. 2020 05; 20(5):1439-1446.
Score: 0.039